Anti-COVID drug developed by DRDO for emergency use gets approved
All the patients who were treated with this showed faster symptomatic cure compared to the Standard of Care (SoC) on various endpoints. An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS). INMAS, a Defence Research and Development Organisation (DRDO), has along with Dr … Read more